Co-Authors
This is a "connection" page, showing publications co-authored by Derek Angus and Christopher Seymour.
Connection Strength
3.845
-
Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness. Crit Care. 2017 Oct 18; 21(1):257.
Score: 0.738
-
Delays From First Medical Contact to Antibiotic Administration for Sepsis. Crit Care Med. 2017 May; 45(5):759-765.
Score: 0.715
-
Precision Medicine for COVID-19: Phenotype Anarchy or Promise Realized? JAMA. 2021 05 25; 325(20):2041-2042.
Score: 0.237
-
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization. Trials. 2021 May 25; 22(1):363.
Score: 0.237
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
Score: 0.227
-
Sepsis Bundles and Mortality Among Pediatric Patients-Reply. JAMA. 2018 12 04; 320(21):2271-2272.
Score: 0.200
-
Validity of the qSOFA Score in Low- and Middle-Income Countries-Reply. JAMA. 2018 11 20; 320(19):2039-2040.
Score: 0.199
-
Association Between the New York Sepsis Care Mandate and In-Hospital Mortality for Pediatric Sepsis. JAMA. 2018 07 24; 320(4):358-367.
Score: 0.195
-
Arguing for Adaptive Clinical Trials in Sepsis. Front Immunol. 2018; 9:1502.
Score: 0.194
-
Epidemiology of Sepsis Among Adolescents at Community Hospital Emergency Departments: Implications for Rory's Regulations. JAMA Pediatr. 2017 10 01; 171(10):1011-1012.
Score: 0.184
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):790-802.
Score: 0.060
-
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):777-789.
Score: 0.060
-
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
Score: 0.060
-
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Open Forum Infect Dis. 2021 Jul; 8(7):ofab254.
Score: 0.059
-
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med. 2021 04 22; 384(16):1491-1502.
Score: 0.058
-
Monocyte Distribution Width: A Novel Indicator of Sepsis-2 and Sepsis-3 in High-Risk Emergency Department Patients. Crit Care Med. 2019 08; 47(8):1018-1025.
Score: 0.052
-
The global burden of sepsis: barriers and potential solutions. Crit Care. 2018 09 23; 22(1):232.
Score: 0.049
-
Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries. JAMA. 2018 06 05; 319(21):2202-2211.
Score: 0.048
-
Children with Chronic Disease Bear the Highest Burden of Pediatric Sepsis. J Pediatr. 2018 08; 199:194-199.e1.
Score: 0.048
-
Prompt Administration of Antibiotics and Fluids in the Treatment of Sepsis: A Murine Trial. Crit Care Med. 2018 05; 46(5):e426-e434.
Score: 0.048
-
Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017 10 03; 318(13):1241-1249.
Score: 0.046
-
Improved Early Detection of Sepsis in the ED With a Novel Monocyte Distribution Width Biomarker. Chest. 2017 09; 152(3):518-526.
Score: 0.045
-
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017 Mar; 45(3):486-552.
Score: 0.044
-
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017 Mar; 43(3):304-377.
Score: 0.044